37 related articles for article (PubMed ID: 8600160)
1. Cyclin-dependent kinase inhibitor 1 plays a more prominent role than activating transcription factor 4 or the p53 tumour suppressor in thapsigargin-induced G1 arrest.
van Zyl E; Peneycad C; Perehiniak E; McKay BC
PeerJ; 2023; 11():e16683. PubMed ID: 38130926
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism.
Ohashi M; Sugikawa E; Nakanishi N
Jpn J Cancer Res; 1995 Sep; 86(9):819-27. PubMed ID: 7591958
[TBL] [Abstract][Full Text] [Related]
3. Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice.
Amson R; Lassalle JM; Halley H; Prieur S; Lethrosne F; Roperch JP; Israeli D; Gendron MC; Duyckaerts C; Checler F; Dausset J; Cohen D; Oren M; Telerman A
Proc Natl Acad Sci U S A; 2000 May; 97(10):5346-50. PubMed ID: 10805794
[TBL] [Abstract][Full Text] [Related]
4. Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein.
Tokumoto YM; Tang DG; Raff MC
EMBO J; 2001 Sep; 20(18):5261-8. PubMed ID: 11566889
[TBL] [Abstract][Full Text] [Related]
5. RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.
Yuan M; Wang Y; Qin M; Zhao X; Chen X; Li D; Miao Y; Otieno Odhiambo W; Liu H; Ma Y; Ji Y
Cancer Sci; 2021 Jul; 112(7):2679-2691. PubMed ID: 33949040
[TBL] [Abstract][Full Text] [Related]
6. Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells.
Birkenmeier G; Hemdan NY; Kurz S; Bigl M; Pieroh P; Debebe T; Buchold M; Thieme R; Wichmann G; Dehghani F
PLoS One; 2016; 11(8):e0161571. PubMed ID: 27579985
[TBL] [Abstract][Full Text] [Related]
7. Apigenin induces DNA damage through the PKCĪ“-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair.
Arango D; Parihar A; Villamena FA; Wang L; Freitas MA; Grotewold E; Doseff AI
Biochem Pharmacol; 2012 Dec; 84(12):1571-80. PubMed ID: 22985621
[TBL] [Abstract][Full Text] [Related]
8. Stress- and Rho-activated ZO-1-associated nucleic acid binding protein binding to p21 mRNA mediates stabilization, translation, and cell survival.
Nie M; Balda MS; Matter K
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10897-902. PubMed ID: 22711822
[TBL] [Abstract][Full Text] [Related]
9. Ras puts the brake on doxorubicin-mediated cell death in p53-expressing cells.
Manna SK; Gangadharan C; Edupalli D; Raviprakash N; Navneetha T; Mahali S; Thoh M
J Biol Chem; 2011 Mar; 286(9):7339-47. PubMed ID: 21156795
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.
Zhang J; Chen X
Curr Mol Med; 2008 Dec; 8(8):845-9. PubMed ID: 19075680
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB is a critical mediator of Ste20-like proline-/alanine-rich kinase regulation in intestinal inflammation.
Yan Y; Dalmasso G; Nguyen HT; Obertone TS; Charrier-Hisamuddin L; Sitaraman SV; Merlin D
Am J Pathol; 2008 Oct; 173(4):1013-28. PubMed ID: 18787102
[TBL] [Abstract][Full Text] [Related]
12. RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript.
Shu L; Yan W; Chen X
Genes Dev; 2006 Nov; 20(21):2961-72. PubMed ID: 17050675
[TBL] [Abstract][Full Text] [Related]
13. N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species.
Goto H; Takahashi H; Fujii H; Ikuta K; Yokota S
Int J Hematol; 2003 Oct; 78(3):219-25. PubMed ID: 14604280
[TBL] [Abstract][Full Text] [Related]
14. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
Akashi M; Osawa Y; Koeffler HP; Hachiya M
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein.
Johannessen LE; Knardal SL; Madshus IH
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):599-606. PubMed ID: 9895307
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells.
Shiohara M; Akashi M; Gombart AF; Yang R; Koeffler HP
J Cell Physiol; 1996 Mar; 166(3):568-76. PubMed ID: 8600160
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]